Various viruses enter host cells via endocytosis, but the molecular mechanisms underlying the specific internalization pathways remain unclear. Here we show that influenza A viruses (IAVs) enter cells via redundant pathways of clathrin-mediated and clathrin-independent endocytosis, with intracellular Ca2+ having a central role in regulation of both pathways by activating a signalling axis comprising RhoA, Rho-kinase, phosphatidylinositol 4-phosphate 5-kinase (PIP5K) and phospholipase C (PLC). IAV infection induces oscillations in the cytosolic Ca2+ concentration of host cells, the prevention of which markedly attenuates virus internalization and infection. The small GTPase RhoA is found both to function downstream of the virus-induced Ca2+ response and itself to induce Ca2+ oscillations in a manner dependent on Rho-kinase and subsequent PIP5K-PLC signalling. This signalling circuit regulates both clathrin-mediated and clathrin-independent endocytosis during virus infection and seems to constitute a key mechanism for regulation of IAV internalization and infection.
Influenza A virus (IAV) is an enveloped virus with a segmented negative-strand RNA genome, which infects a wide variety of birds and mammals. IAV infection is a complex, multistep process. In the initial step (adsorption), the virus attaches to a host cell through binding of its major surface protein, haemagglutinin (HA), to sialylated cell surface proteins. In the second step (internalization or entry), the adhered viral particle enters the cell as a result of invagination of the surface membrane and is delivered from the endocytic vesicle to early endosomes. Finally, in late endosomes, the virus fuses with the endosomal membrane and thereby releases its genome into the cytosol for replication of viral genes and the production of viral components1. Clathrin-mediated endocytosis (CME), the most well-characterized endocytic pathway, is the major route of IAV internalization2,3. Live cell imaging has thus revealed the de novo formation of clathrin-coated pits at the site of virus attachment4 and, among the adaptor proteins that contribute to CME, Epsin1 has been found to be required for this process5. Recent studies have provided evidence for an alternative pathway of IAV internalization, however. Neither pharmacological inhibition of CME, expression of a dominant-negative form of Eps15, knockdown of Epsin1 nor the introduction of monoclonal antibodies to clathrin was found to inhibit IAV infection3,5,6. In addition, viruses have been found to enter cells simultaneously via non-coated pits as well as via clathrin-coated pits5. Nevertheless, the mechanism of this alternative means of cell entry exploited by influenza viruses has remained unclear.
We recently showed that Ras-phosphoinositide 3-kinase (PI3K) signalling in the host cell regulates IAV internalization7. The binding of Ras to PI3K and subsequent PI3K activation in endosomes regulate clathrin-independent endocytosis (CIE) and IAV internalization through this route. We now investigate the mechanism of Ras activation by IAVs and identify Ca2+ as a mediator of this event. Moreover, we show that Ca2+ signalling has an indispensable role in IAV infection, not only through the control of CIE via Ras activation but also through that of CME via mobilization of a novel positive feedback circuit consisting of RhoA, Rho-kinase (ROCK), phosphatidylinositol 4-phosphate 5-kinase (PIP5K), phospholipase C (PLC) and Ca2+ per se.
Ras activation by IAVs is mediated by intracellular Ca2+
To explore the mechanism by which Ras is activated during IAV infection, we first examined whether intracellular Ca2+, one of the upstream regulators of Ras8, was increased after infection of mouse embryonic fibroblasts (MEFs) with the A/Puerto Rico/8/34 (H1N1; PR8) virus strain. Yellow Cameleon 3.60 (YC3.60), a Ca2+ sensor based on Förster resonance energy transfer (FRET) from cyan fluorescent protein (CFP) to yellow fluorescent protein9, revealed oscillations in the cytosolic Ca2+ concentration ([Ca2+]i) associated with virus infection, albeit with substantial variation in the amplitude and frequency of such oscillations among cells (Fig. 1a–c; Supplementary Fig. S1a). Of note, cells expressing the FRET-based biosensors that had been subjected to the analysis were certainly infected with IAV, as revealed by immunofluorescent labelling of the virus nucleoprotein (NP) (Supplementary Fig. S1b; see also Supplementary Fig. S6d). In MDCK cells, PR8, in addition to histamine or fetal bovine serum (FBS; known factors that increase [Ca2+]i, refs 10, 11), also evoked Ca2+ oscillations, whereas PBS (solvent of the IAV stock solutions) failed to do so (Supplementary Fig. S1c–f). Similar Ca2+ oscillations could be observed in Cos-1 cells (Supplementary Fig. S1g), indicating that IAVs have a potential to elevate Ca2+ in different cell lines. Given that another viral subtype, A/Aichi/2/68 (H3N2), also evoked [Ca2+]i oscillations (Supplementary Fig. S1h), this property did not appear to be restricted to a particular viral strain.
We further found that Ras activation by IAVs was abolished by chelation of intracellular Ca2+ with BAPTA-AM, as revealed with both a FRET-based Ras activation sensor12 and a pull-down assay (Fig. 1d–g). In addition, the extracellular Ca2+ chelator EGTA also inhibited both Ras activation and [Ca2+]i increase by IAVs (Fig. 1e–g), demonstrating the requirement for extracellular Ca2+ in these phenomena. On the other hand, immunoblot analysis with two different antibodies specific for phosphotyrosine (clones 4G10 and PY20) revealed no substantial differences in the tyrosine phosphorylation status of cellular proteins between infected and non-infected cells (Supplementary Fig. S2a,b), indicating that IAVs activate Ras via Ca2+ signalling.
Next, to investigate the mechanism(s) through which IAVs induced [Ca2+]i increase and subsequent Ras activation, we prepared virus-like particles (VLPs) from 293T cells transfected with expression vectors for HA, neuraminidase (NA) and matrix protein 1 and 2 (M1 and M2)13,14. Cell culture media containing VLPs, but not those from mock-transfected 293T cells, induced Ca2+ oscillations (Supplementary Fig. S2c). Sialidase treatment15,16 inhibited Ca2+ increases by both VLP and PR8 (Supplementary Fig. S2c,d), suggesting that attachment of virus particles to sialic acid-containing cell surface molecule(s) has a role in the Ca2+ elevation. Among Ras activators, a family of Ca2+- and diacylglycerol (DAG)-regulated guanine nucleotide exchange factors (CalDAG-GEFs, also known as RasGRPs)17,18,19 was a plausible candidate for mediating Ras activation by IAVs, given that this class of GEFs is not only activated by Ca2+ but also participates in the regulation of Ras in endomembrane compartments including the Golgi apparatus20. Expression of the EF-C1 domain of CalDAG-GEFII, which acts in a dominant-negative manner as a result of the absence of the catalytic domain (Supplementary Fig. S2e), suppressed virus-induced Ras activation (Fig. 1h), but not Ca2+ oscillations (Supplementary Fig. S2f) in Cos-1 cells, implicating CalDAG-GEF as a Ras activator in this pathway.
Ca2+ is a key factor in virus internalization and infection
We next evaluated the effect of thapsigargin, an inhibitor of sarcoendoplasmic reticulum Ca2+ ATPases, on IAV infection. The titre of progeny viruses was markedly increased for MDCK cells treated with thapsigargin at a low dose compared with that for control cells, and dose-dependently reduced at higher doses (Supplementary Fig. S3a). Given that thapsigargin raises [Ca2+]i by blocking the sarcoendoplasmic reticulum Ca2+ ATPases pumps, which thereby causes endoplasmic reticulum stores to become depleted21, this result might indicate that intracellular Ca2+ released from endoplasmic reticulum is crucial for IAV infection and replication. In contrast, BAPTA-AM remarkably reduced the production of progeny viruses (Fig. 2a; Supplementary Fig. S3b). Unexpectedly, given that Ca2+ was shown to be an upstream regulator of Ras, the inhibitory effect of BAPTA-AM on progeny virus production was much greater than that of the PI3K inhibitor LY294002 (Fig. 2a). As LY294002 almost completely inhibited basal and IAV-induced phosphorylation of Akt, the most established downstream molecule of PI3K (Supplementary Fig. S3c), it is clear that Ca2+ also regulates a pathway other than Ras-PI3K signalling. To determine the stage of the virus life cycle at which Ca2+ signalling is required, we treated cells with BAPTA-AM according to three different regimens: (i) during the early infection stage (from 30 min before infection to 4 h post-infection (hpi)), (ii) during the late stage (from 4 to 24 hpi) and (iii) during both stages. The former two correspond to the periods before and after replication initiation, respectively7,22 (Supplementary Fig. S3d). Chelation of Ca2+ during the early or late stages resulted in a significant reduction in progeny virus production, whereas continuous treatment during both stages inhibited infection to an even greater extent (Fig. 2b), suggesting that Ca2+ functions during both stages. BAPTA-AM treatment during the early stage suppressed infection more efficiently than did LY294002 (Supplementary Fig. S3e), again indicative of an effect of Ca2+ chelation on a viral entry pathway other than Ras-PI3K-dependent CIE.
Influenza viruses enter cells via both CME and CIE5,6,7, and recent reports have broadened their entry pathway to macropinocytosis23,24. To examine the relations among Ca2+, endocytosis and virus infection, we established an assay system based on imaging techniques to directly visualize internalized virus particles and evaluate virus internalization at a single-cell level (Supplementary Fig. S4a,b). The time course of the number of visualized virus particles and their co-localization with Rab7 (a late endosome marker) was consistent with that obtained by immunoblotting with an anti-M1 antibody (Supplementary Fig. S3d) and a previous report25. In addition, it could be clarified that virus internalization was dramatically abrogated with the inhibition of endocytosis at 4 °C (Supplementary Fig. S4c,d); the established analysis was therefore rational and utilized hereafter.
Monodansylcadaverine (MDC), an inhibitor of CME26, attenuated virus internalization by the CME pathway (Fig. 2c), but it did not affect total virus internalization (Fig. 2d) under conditions where CME was dramatically suppressed (Fig. 2e). Influenza viruses thus enter host cells via the CIE pathway, including macropinocytosis, even when CME is inhibited, as has been shown previously5,6,7,27,28. Indeed, MDC had no effect on overall virus infection (Fig. 2a; Supplementary Fig. S5a). A similar inhibitory profile was displayed in cells expressing the dominant-negative mutant of Eps15 (dnEps15, Fig. 2e,f; Supplementary Fig. S5a,b), a critical regulator of CME6. Suppression of CIE by the PI3K inhibitor LY294002 (ref. 7; Fig. 2f) resulted in only a partial reduction in overall infection (Fig. 2a; Supplementary Fig. S5a). In addition, treatment with the inhibitor of macropinocytosis 5-(N-ethyl-N-isopropyl)-amiloride (EIPA)29 caused no significant reduction in IAV infection (Fig. 2a) under the condition where dextran uptake was suppressed (Fig. 2f). Simultaneous inhibition of both CME and CIE (or macropinocytosis), however, resulted in suppression of virus internalization (Fig. 2d) and infection (Fig. 2a) to an extent greater than that observed with inhibition of either pathway alone. Treatment with BAPTA-AM inhibited both CME and CIE, as evaluated by measurement of the uptake of transferrin (Fig. 2e) and dextran (Fig. 2f), respectively. Moreover, Ca2+ chelation inhibited virus internalization (Fig. 2g; Supplementary Fig. S5c) and infection (Fig. 2a; Supplementary Fig. S5a) to an extent similar to that apparent with combined treatment with MDC and LY294002 or MDC and EIPA. Altogether, these results indicate that Ca2+ signalling is required for both CME- and CIE-mediated virus internalization and that simultaneous inhibition of both these pathways is an effective strategy to block influenza virus infection. Such inhibition can be achieved by combined treatment with MDC and LY294002 (or EIPA) or by treatment with BAPTA-AM alone. Further, this effect of BAPTA-AM was also manifested in both Cos-1 cells and A549 human lung cancer cells (Supplementary Fig. S5d,e), indicating that Ca2+ is generally required for virus internalization in a cell type-independent manner.
RhoA and Rac1 activation during IAV infection
We next investigated the downstream effectors of Ca2+ signalling that regulate endocytosis. Given that GTPases of the Rho family are thought to have important roles in vesicular trafficking and to act downstream of Ca2+ (refs 30, 31), we examined the possible contribution of these proteins to virus internalization. Expression of a dominant-negative mutant (N19) of RhoA resulted in marked inhibition of virus infection and internalization in MDCK cells, whereas that of wild-type RhoA enhanced both infection and internalization (Fig. 3a,b; Supplementary Fig. S6a). Expression of a constitutively active form (V14) of RhoA also inhibited virus infection and internalization, indicating a requirement for the GTP-GDP cycle of RhoA. Whereas RhoA activation by IAVs was not detected with a pull-down assay (Fig. 3c; Supplementary Fig. S6b), it was detected, albeit in a restricted region at the peripheral cell membrane (Fig. 3d; Supplementary Fig. S6c), with the use of a FRET-based RhoA activation sensor32. Here it might also be worth mentioning that the FRET-based biosensors utilized in this study did not inhibit IAV infection (Supplementary Fig. S6d).
VLPs also activated RhoA at the cell periphery (Supplementary Fig. S7a) and both PR8- and VLP-induced RhoA activation was inhibited by BAPTA-AM (Fig. 3e; Supplementary Fig. S7a,d), consistent with the notion that RhoA is activated downstream of Ca2+ in a spatiotemporally dependent manner. Similarly, expression of dominant-negative (N17) or constitutively active (V12) forms of Rac1 also inhibited virus infection or internalization (Fig. 3a,b; Supplementary Fig. S6a), with IAV-induced activation of Rac1 being detected with both pull-down and FRET-based33 assays (Fig. 3c,f) and being inhibited by BAPTA-AM (Fig. 3f; Supplementary Fig. S7b). In contrast, expression of dominant-negative (N17) or constitutively active (V12) variants of Cdc42 had no significant effect on virus infection (Fig. 3a; Supplementary Fig. S6a), and no marked activation of Cdc42 by IAVs was observed with pull-down (Fig. 3c) or FRET (Supplementary Fig. S7c) assays. These results thus indicate that Cdc42 is dispensable for influenza virus infection.
We also examined the effects of exogenous RhoA or Rac1 expression on endocytosis in MDCK cells. The uptake of both transferrin and dextran was enhanced by wild-type RhoA and inhibited by its dominant-negative mutant (Fig. 3g,h), indicating that RhoA promotes both CME and CIE. On the other hand, Rac1 expression affected only the uptake of dextran (Fig. 3g,h), suggesting that Rac1 regulates CIE but not CME, consistent with previous observations34,35. We examined the molecular hierarchy among RhoA, Rac1 and Ras. Activation of Rac1, but not that of RhoA, was inhibited by expression of a dominant-negative form (N17) of H-Ras (Fig. 3f,i; Supplementary Fig. S7d). Further, expression of the dominant-negative form of RhoA suppressed IAV-dependent Ras activation, whereas that of the dominant-negative form of Rac1 did not (Fig. 3j). These results thus indicate that RhoA acts upstream of Ras and Rac1, and that Rac1 functions downstream of Ras.
RhoA promotes Ca2+ oscillations
Unexpectedly, we noticed that RhoA also acts as an upstream regulator of Ca2+. Expression of the dominant-negative variant of RhoA in Cos-1 and MDCK cells prevented the infection-evoked [Ca2+]i oscillations observed in control cells, whereas the expression of wild-type RhoA increased the frequency of such oscillations (Fig. 4a; Supplementary Fig. S8a). Expression of Rac1 did not affect virus-induced Ca2+ oscillation (Fig. 4a), indicating that the reciprocal regulatory relation between RhoA and Ca2+ is specific. Substantial Ca2+ oscillations were also apparent in cells expressing wild-type RhoA before virus infection (Fig. 4a). Indeed, both wild-type and constitutively active forms of RhoA, but not Rac1 or Cdc42, induced Ca2+ oscillation in the absence of extracellular stimuli, the amplitudes and frequencies of which differed among cell lines (Fig. 4b; Supplementary Fig. S8b). These observations therefore suggested that GTP-RhoA and Ca2+ constitute a positive feedback loop, with RhoA not only being activated by Ca2+ but also inducing subsequent [Ca2+]i elevation during virus infection.
Requirement for PIP5K in virus internalization and infection
PIP5K has been shown to regulate endocytosis36,37 downstream of Rho-family GTPases38. We examined the role of PIP5K in the regulation of CME and CIE with the use of MEFs isolated from wild-type and PIP5Kα-deficient (PIP5K−/−) mice39. The uptake of both transferrin and dextran was reduced in PIP5K−/− MEFs compared with that in wild-type cells (Fig. 5a,b), as were the internalization (Fig. 5c) and progeny production of IAVs (Fig. 5d). Further, virus-dependent [Ca2+]i oscillations were reduced in frequency and delayed in PIP5K-deficient cells compared with those in wild-type cells (Fig. 5e–h).
Next, we examined whether IAVs and RhoA indeed activated PIP5K. PIP5K is reported to be tyrosine-phosphorylated and unphosphorylated in its inactive and active forms, respectively, the difference between which can be distinguished by the electrophoretic mobility shift40. The slower migrating fractions of PIP5K were decreased on PR8 infection in a time-dependent manner (Supplementary Fig. S9a), and by expression of wild type and the activated mutant of RhoA, whereas its dominant-negative mutant failed to do so (Supplementary Fig. S9b). In addition, both PR8 and wild-type RhoA promoted the translocation of PIP5K from the cytoplasm to the plasma membrane and the Golgi (Supplementary Fig. S9c), where PIP5K is known to be activated41, whereas expression of dominant-negative form of RhoA suppressed PR8-induced PIP5K translocation. Further, RhoA-dependent Ca2+ oscillations were substantially suppressed in PIP5K−/− cells (Fig. 5i), indicating that RhoA-dependent PIP5K activation modulates IAV-induced Ca2+ signalling.
ROCK as an adaptor bridging RhoA and PIP5K
Given that ROCK has an important role in RhoA-PIP5K signalling38,42, we investigated whether ROCK participates in the regulation of IAV-induced Ca2+ signalling. The ROCK inhibitor Y-27632 (ref. 43) did not affect CME or CIE in MDCK cells (Supplementary Fig. S10a,b). Moreover, whereas BAPTA-AM suppressed RhoA-induced Ca2+ oscillations, Y-27632 failed to do so (Fig. 6a,b), although it disrupted the organization of actin stress fibres (Supplementary Fig. S10c). These results thus suggested that the kinase activity of ROCK is dispensable for endocytosis and RhoA-induced Ca2+ signalling. Instead, CIE seemed to be inhibited by excess activation of ROCK, given that Y-27632 reversed the inhibitory effect of the constitutively active mutant of RhoA on dextran uptake (Supplementary Fig. S10d). RhoA has been shown to interact directly with PIP5K irrespective of the bound nucleotide41,44. To further confirm the requirement for activated RhoA in an IAV-dependent Ca2+ signalling, we made use of the Rho-binding domain (RBD) of ROCK1, which, through the trapping of GTP-RhoA, exerts a dominant-negative effect on its downstream effectors including ROCK45. Expression of the RBD suppressed virus-dependent and RhoA-dependent Ca2+ oscillations (Fig. 6c,d), endocytic activity (Supplementary Fig. S10e,f) as well as virus infection and internalization (Fig. 6e,f; Supplementary Fig. S10g). These results indicated that RhoA mediates virus-evoked signalling in a manner dependent on its binding of GTP.
We then revisited the relevance of ROCK to GTP-RhoA-mediated PIP5K activation by depleting MEFs of endogenous ROCK through transfection with specific short interfering RNAs (siRNAs). The knockdown efficiencies for ROCK1 and ROCK2 with corresponding siRNAs were ~70% and ~30%, respectively (Supplementary Fig. S11a,b). Knockdown of ROCK1 or ROCK2 alone resulted in partial inhibition of both IAV- and RhoA-dependent Ca2+ oscillations, whereas the simultaneous knockdown of both proteins resulted in almost complete inhibition (Fig. 6g,h; Supplementary Fig. S11c). Consistent with these results, knockdown of ROCK1 or ROCK2 alone had a minimal effect on IAV infection, whereas simultaneous depletion of both ROCK isoforms effectively reduced infection (Fig. 6i). ROCK1 and ROCK2 thus participate in RhoA-mediated PIP5K activation and IAV infection in a manner independent of their kinase activity. This conclusion was further confirmed by the observation that expression of wild-type human ROCK1 or a kinase-defective mutant thereof restored IAV infection and internalization in MEFs depleted of endogenous ROCK1 and ROCK2 (Fig. 6j,k). Altogether, our results indicate that RhoA-bound ROCK, but not the kinase activity of ROCK, is essential for RhoA-dependent Ca2+ signalling and IAV infection.
PLC is required for RhoA-dependent Ca2+ oscillations
Finally, we attempted to identify the mechanism by which Ca2+ signalling is regulated by PIP5K. Given the established role of PLC in the conversion of phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate (IP3) and DAG, we examined the effect of the PLC inhibitor U73122 (ref. 46) on IAV-induced Ca2+ oscillations. Exposure of Cos-1 cells to U73122 prevented the increase in [Ca2+]i triggered by infection with PR8 (Fig. 7a) as well as the spontaneous Ca2+ oscillations apparent in cells overexpressing wild-type RhoA (Fig. 7b). Further, U73122 prevented IAV internalization (Fig. 7c), and similar inhibitory profiles could be observed when another PLC inhibitor edelfosine46,47 was utilized (Supplementary Fig. S12a,b). In addition, these reagents dramatically inhibited peripheral RhoA activation by PR8 (Fig. 7d; Supplementary Fig. S12c compared with Fig. 3d and Supplementary Fig. S6c). Altogether, our results thus suggest that the positive feedback loop between Ca2+ and RhoA, which is mediated by ROCK, PIP5K and PLC, governs both CME and CIE, with the latter being regulated by the CalDAG-GEF-Ras-PI3K-Rac1 pathway (Fig. 8). This signalling network provides an acceptor system of host cells for IAV internalization through which IAVs, indeed, activate both CME and CIE to produce a favourable circumstance for their entry (Supplementary Fig. S13a,b).
We have shown here that an increase in [Ca2+]i is required for IAV infection and internalization via CIE and CME, and that RhoA, in cooperation with ROCK, PIP5K and PLC, regulates this Ca2+ signalling and is itself regulated by Ca2+. We and others have previously shown that PI3K is required for CIE and influenza virus infection7,22, and Epsin1 has been found to be required for virus internalization via CME5. However, the molecular mechanisms by which influenza viruses exploit CIE and CME for their efficient internalization by host cells have remained unclear. We now unveil the host cell machinery, consisting of Ca2+-RhoA-ROCK-PIP5K-PLC and CalDAG-GEFs-Ras-PI3K-Rac1, that contributes this phenomenon (Fig. 8).
Intracellular Ca2+ has previously been implicated in IAV infection48,49, with Ca2+ having been thought to have a role in the late stage of infection. For instance, Ca2+ acting through calmodulin is required for the transcription and replication of IAV genes48,49, with inhibition of such Ca2+ action being expected to attenuate viral messenger RNA replication in the nucleus. Consistent with this notion, we found that BAPTA-AM treatment during the late stage of IAV infection inhibited the generation of progeny viruses, albeit less efficiently than that during the early stage. However, we have also unveiled a hitherto unknown function of Ca2+ in IAV internalization through the regulation of CME and CIE. Indeed, Ca2+ oscillations were observed immediately after exposure of cells to the virus. Although the precise mechanism by which IAVs induce [Ca2+]i elevation remains obscure, the elimination of Ca2+ signalling by BAPTA-AM resulted in almost complete inhibition of virus internalization. In addition to this central role of Ca2+ in IAV infection, Ca2+ is also implicated in apoptosis of cells infected by a highly pathogenic H5N1 virus50, suggesting that the development of agents that target Ca2+ signalling might provide a new approach to the prevention and treatment of infection with a variety of influenza subtypes.
The [Ca2+]i is maintained at a low level under basal conditions, with increases triggering a variety of cellular responses including gene expression and the release of humoral factors51,52. In most instances, increases in [Ca2+]i occur in the form of oscillations, which are maintained by a sustained increase in IP3 levels53. The RhoA-ROCK-PIP5K-PLC pathway identified in the present study probably contributes to the maintenance of IP3 levels and subsequent Ca2+ oscillations during influenza virus infection. Such Ca2+ oscillations in turn activate RhoA; through this positive feedback loop, RhoA, in cooperation of Ca2+, has indispensable roles for IAV internalization. With progression of internalization and infection, the input signal from the cell surface to any component molecule (possibly an initial Ca2+ increase via sialylated proteins) becomes attenuated, leading to the consequent decay of the entire signalling circuit in a time-dependent manner, as recorded by time-lapse microscopy.
Although growing evidence implicates Ca2+ in RhoA signalling54,55,56, little has been reported about the factor articulating these two molecules. The activity of small GTPases is regulated by the balance between the activities of GEFs and GTPase-activating proteins. A myriad of the regulators have been identified over the last decades and the largest family of RhoGEFs comprises the Dbl-family RhoGEFs with 70 human members57. Coupled with the redundancy in substrate recognition across the GEF family58, the diversity and complexity of GTPase regulation may have prevented us from narrowing down the focus to definitive candidates. In fact, as far as we are aware, PDZ-RhoGEF (ARHGEF11) is only a RhoA-specific GEF that links Ca2+ signalling to RhoA56. However, it unlikely contributes to RhoA activation during IAV infection, given that the protein tyrosine kinase Pyk2, a key factor for PDZ-RhoGEF activation by Ca2+ signalling downstream of G-protein-coupled receptor, has not previously been implicated in influenza virus infection. Further studies, including a search for relevant GTPase-activating proteins, are therefore required to clarify the molecular linkage between Ca2+ and RhoA, the mechanism for spatiotemporally specific regulation of RhoA and their contribution to subsequent virus infection.
The pathway of virus entry into cells, including that of IAVs, is one of the most studied aspects of the viral life cycle4,59,60. Although considerable effort has been devoted to identifying molecules involved in these pathways, simple inhibition of CME or CIE has yielded only partial effects on infection2,3,4,5,7,23,28 (see also Fig. 2a,d) or displayed cell-type-specific inhibition61. Similarly, the contribution of GTPases, namely Rac1, to the regulation of entry pathways could be varied across cell types or virus strains23,24. In addition, in the presence of serum, IAVs exploit macropinocytosis, a class of CIE, as a primary entry route (Supplementary Fig. S5f,g)23. Hence, the bias between CME and CIE exists in a cell context- and condition-dependent manner and, on inhibition of one of these redundant pathways, IAVs tend to switch to the other pathway to achieve internalization. We have now shown that simultaneous inhibition of both CME and CIE (including macropinocytosis) resulted in suppression of IAV infection effectively, suggesting that CME and CIE are the predominant entry pathways for IAVs. Given that the signalling circuit identified in the present study operates at a branch point of CME and CIE, our results may provide a basis for the development of improved strategies for treatment or prevention of IAV infection.
Expression vectors for GFP-Rab7, GFP-CLCa, GFP-dnEps15 and the FRET-based biosensor YC3.60 (ref. 9) were kindly provided by T. Tsuboi (University of Tokyo, Japan), Y. Kawaoka (University of Wisconsin, Madison, USA), A. Dautry-Varsat (the Pasteur Institute, France) and A. Miyawaki (Riken, Wako, Japan), respectively. The complementary DNA for mouse CalDAG-GEFII, expression vectors for wild-type and mutant human GTPases and those for FRET-based GTPase biosensors (Raichu-Ras (146X), Raichu-RhoA (1293X), Raichu-Rac1 (1026X) and Raichu-Cdc42 (1069X))12,26,32,33 were kindly provided by M. Matsuda (Kyoto University, Japan). pCAGGS-HA, pCAGGS-NA, pCAGGS-M1 and pCAGGS-M2, vectors for generation of VLPs, were obtained from Y. Kawaoka. Expression plasmids for human ROCK1 or its kinase-dead (KD) mutant and that for GFP-PIP5K, pCAGGS-myc-ROCK1 and pCAGGS-myc-ROCK1-KD were described previously43,62. The coding sequences for the EF-C1 domain of mouse CalDAG-GEFII and the RBD of human ROCK1 were amplified by PCR, followed by subcloning into the XhoI and NotI sites of the pCAGGS-Flag-IRES-ExRed vector63. The vectors for GTPases, the EF-C1 domain of CalDAG-GEFII and the RBD of ROCK1 were bicistronic to allow monitoring of expression on the basis of the fluorescence of the encoded ExRed.
Cells and transfection
MEFs deficient in PIP5K (PIP5Kα encoded by PIPKIα gene) were prepared from 12.5 days post-coitum mouse embryos as described previously39. Briefly, embryos were collected, the brain and internal organs were removed and the carcasses were minced and incubated with trypsin for 30–45 min at 37 °C. DMEM supplemented with 10% FBS was added to the cell suspension and the cells were further disaggregated. Homogeneous cell suspensions were added to 90-mm dishes containing 10 ml of media. MEFs, Cos-1 (JCRB9082), HEK293T (CRL-11268) and A549 (CCL-185) cells were maintained under a humidified atmosphere of 5% CO2 at 37 °C in DMEM supplemented with 10% FBS, whereas MDCK cells (CCL-34) were maintained in MEM medium (Sigma) with 10% FBS. Expression vectors were introduced into MEFs by nucleofection with the use of an Amaxa (Cologne, Germany) instrument (solution V, program T-20). The FuGene HD reagent (Roche) was used for transfection into other cell types. In principle, MEFs and Cos-1 cells were utilized in knockout/knockdown and overexpression experiments, respectively, whereas MDCK cells were used for assessment of endocytosis/virus internalization. A549 was employed as a model for airway epithelial cells.
Reagents and antibodies
Hoechst 33342, AlexaFluor488- or AlexaFluor546-labelled dextran (10 kDa), AlexaFluor546-labelled transferrin, AlexaFluor 594-conjugated phalloidin and AlexaFluor488-, AlexaFluor594- or AlexaFluor647-conjugated antibodies to mouse immunoglobulin were obtained from Invitrogen (Carlsbad, CA). Platelet-derived growth factor (50 ng ml−1), histamine (100 μM) and phorbol 12-myristate 13-acetate (100 nM) were obtained from PeproTech (Rocky Hill, NJ), Nacalai Tesque (Kyoto, Japan) and Sigma (St Louis, MO), respectively. LY294002 (used at 50 μM), Y-27632 (10 μM) and U73122 (5 μM) were obtained from Calbiochem (San Diego, CA), and MDC (50 μM), acetoxymethyl ester of 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetra acetic acid (BAPTA-AM, 25 μM), EIPA (100 μM), sialidase from Vibrio cholerae (5mU ml−1) and thapsigargin were from Sigma. Of note, some of the above reagents were employed at a concentration at which ~95% inhibitory effect could be obtained, according to the previous reports (LY294002, 50 μM (ref. 64); EIPA, 100 μM (ref. 65)) or results of our preliminary experiments (MDC, 50 μM; BAPTA-AM, 25 μM; Supplementary Fig. S14). Antibodies to Ras (Ab-3) were obtained from Oncogene (Cambridge, MA), those to RhoA (26C4) and β-actin (I-19) were from Santa Cruz Biotechnology (Santa Cruz, CA), those to Cdc42 (#05-542) were from Millipore (Billerica, MA), those to Rac1 (clone 10) were from BD Bioscience (San Diego, CA), those to phospho-Akt (S473), Akt, ROCK1 (C8F7) and ROCK2 were from Cell Signaling (Danvers, MA) and those to IAV M1 (GA2B) were from Abcam (Cambridge, MA). The 4G10 and PY20 antibodies to phosphotyrosine were obtained from Millipore and BD Bioscience, respectively. Antibodies to NP and GFP were kindly provided by A. Takada (Hokkaido University) and M. Matsuda, respectively.
IAV strains PR8 and A/Aichi/2/68 (H3N2) were propagated in the chorioallantoic cavity of 10-day-old embryonated chicken eggs for 48 h at 37 °C. After high-speed centrifugation, the purified viruses were resuspended in PBS buffer and stored at −80 °C until use. Cells were infected with PR8 at a multiplicity of infection (MOI) of 1 p.f.u. per cell at 37 °C. The amount of infectious virus in culture supernatants was determined with a plaque assay as described previously66,67. Briefly, confluent monolayers of MDCK cells in 12-well plates were inoculated with the supernatants. After 1 h of adsorption, the cell supernatants were removed, and the cells were overlaid with MEM containing 1% Bact-agar and trypsin (5 mg ml−1). Plaques were enumerated after incubation at 35 °C and 5% CO2 for 2 days.
Generation of VLPs
Generation of VLPs was conducted according to the previous report13,14. Briefly, 293T cells (1 × 106 cells) in a 6-cm-diameter dish were transfected with expression vectors for PR8 HA, NA, M1 and M2 and at 6 hpi, the medium was replaced with OPTIMEM (Invitrogen). After 48 h, the culture medium was collected, subjected to centrifugation at 2,000 g for 10 min to remove cell debris and then used for analysis. Culture media obtained from cells transfected with empty vectors were used as a negative control.
Immunoblot analysis and pull-down assay for small GTPases
Unless otherwise specified, cells were lysed in RIPA buffer (50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM Na3VO4) for 20 min on ice. For detection of phosphorylated and unphosphorylated PIP5K, Cos-1 cells expressing GFP-PIP5K were infected with PR8 at an MOI of 10 for 0, 30 and 60 min or stimulated with phorbol 12-myristate 13-acetate for 30 min. Cells were lysed in a solution containing 10 mM Tris–HCl, pH 7.4, 150 mM NaCl, 30 mM sodium pyrophosphate, 0.5% Nonidet P-40, 5 mM EDTA, 10% glycerol, 50 mM NaF, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 10 μg ml−1 aprotinin and 10 μg ml−1 leupeptin for 30 min on ice. The lysates were centrifuged at 20,000 g for 10 min at 4 °C, and the resulting supernatants were subjected to SDS–polyacrylamide gel electrophoresis. The separated proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA) and subjected to immunoblot analysis. Immune complexes were detected with the use of ECL Western Blotting Detection Reagent (GE Healthcare, Little Chalfont, UK) and an LAS-1000UVmini image analyser. Detection of GTP-bound Ras- and Rho-family GTPases was performed essentially as described previously68,69, with slight modifications63,70. For detection of the active forms of Ras, Rac1 or Cdc42 cells were lysed in lysis buffer (50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 5 mM MgCl2, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM Na3VO4). After centrifugation, the resulting supernatants were incubated for 30 min at 4 °C with glutathione S-transferase (GST) fusion proteins containing the Ras-binding domain of c-Raf-1 or the Cdc42/Rac-interactive binding domain of Pak2. The resulting complexes of GTP-bound GTPases and GST fusion proteins were precipitated with the use of glutathione-Sepharose beads (GE Healthcare), washed twice with lysis buffer and eluted. Alternatively, for detection of active RhoA, cells were lysed in a solution containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 30 mM MgCl2, 0.1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, aprotinin (1 μg ml−1), leupeptin (1 μg ml−1) and a GST fusion protein containing the RBD of rhotekin. The lysates were clarified by centrifugation, and the complex of GTP-bound RhoA and GST-rhotekin (RBD) was precipitated from the resulting supernatants, washed and eluted. Activated GTPases were then detected by immunoblot analysis with antibodies specific for each protein. Full scans of all immunoblots are supplied in Supplementary Fig. S15.
Cells were imaged with an Olympus IX-71 microscope equipped with BioPoint MAC5000 excitation and emission filter wheels (Ludl Electronic Products, Hawthorne, NY) and a MicroMAX 512BFT cooled charge-coupled device camera (Princeton Instruments, Trenton, NJ). The following filters were used in this study: XF1071 and XF3075 (Omega Optical, Brattleboro, VT) for CFP; BP470-490 and BP510-550 (Olympus) for GFP and AlexaFluor488; XF1068 and XF3079 (Omega Optical) for yellow fluorescent protein; BP520-550 and BA580IF (Olympus) for ExRed, AlexaFluor546 and AlexaFluor594; and XF1071 and XF3079 for FRET. An XF2034 dichroic mirror (Omega) was used throughout experiments. Cells were illuminated with a 75-W-xenon lamp through a 6% neutral density (ND) filter. Exposure times for 2 × 2 binning were 0.5 s and 30 ms for fluorescence images and differential interference contrast images, respectively. MetaMorph software (Universal Imaging, West Chester, PA) was used for control of the charge-coupled device camera and filter wheels, as well as for analysis of cell-imaging data. FRET imaging and data analysis were performed essentially as described previously12,26,32,33. In brief, cells were transfected with vectors for biosensors for 24 h, deprived of serum for 4 h and placed in a chamber on a microscope in which the temperature was maintained at 37 °C. A differential interference contrast image as well as CFP and FRET fluorescence images were recorded every 30 s. After 10–15 min, the cells were infected with PR8. In some experiments, cells were exposed to inhibitors for 30 min before infection. FRET efficiency was calculated as a quotient of background-subtracted FRET and CFP images and was presented in an intensity-modified display mode with MetaMorph software. In the intensity-modified display mode shown here, eight colours from red to blue are used to represent the emission ratio, with the intensity of each colour indicating the mean intensity of FRET and CFP as indicated.
For immunofluorescence staining, cells were fixed with 3% paraformaldehyde for 15 min at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 4 min at room temperature and then incubated with 1% bovine serum albumin to block nonspecific binding of antibodies. The cells were further incubated with primary antibodies (NP, 1:1,000 dilution; c-Myc, 1:1,000 dilution) overnight at 4 °C, after which immune complexes were detected by incubation for 1 h at room temperature in the dark with AlexaFluor488-, AlexaFluor594- or AlexaFluor647-conjugated secondary antibodies (1:250 dilution). For visualization of actin stress fibres, cells were fixed, permeabilized and then incubated with AlxaFluor594-conjugated phalloidin (1:50 dilution; Invitrogen) for 30 min at 37 °C in the dark. Images were acquired with an FV-10i confocal microscope (Olympus, Tokyo, Japan) or an epifluorescence microscope.
Virus internalization and infection assays
Cells expressing GFP-Rab7 as a marker of late endosomes or GFP-CLCa as a marker of clathrin-coated vesicles were serum starved in phenol red-free DMEM/F12 for 4 h and incubated with PR8 at an MOI of 10 (prepared by dilution of virus stock in conditioned medium) for 1 h (Rab7) or 30 min (CLCa) at 37 °C. In some experiments, inhibitors were added to culture media before the infection. After fixation, the internalized virus particles were visualized by immunostaining with antibodies to NP. Confocal sections (with a z step of 0.2 μm) were acquired from the bottom to the top of the cells and, after background subtraction, all sections were projected on one image plane to visualize all virus particles simultaneously. Vesicles positive for NP or either Rab7 or CLCa were extracted with the use of the ‘granularity’ module of MetaMorph software, and the co-localization of NP with either Rab7 or CLCa was quantified with the ‘measure co-localization’ function. Of note, during our experimental period, NP co-localization with Rab7 was indicative of viruses that were internalized into cells and reached late endosomes, whereas NP-positive and Rab7-negative granules represent the other fractions of particles, including those localizing in early endosome and those adsorbing on the plasma membrane (but not being internalized). Therefore, a decrease in NP co-localization with Rab7 (and a concomitant increase in NP signal without the co-localization) can be observed when virus internalization is inhibited or delayed. Evaluation of virus internalization by immunoblotting was performed as reported previously25. In brief, cells were washed with PBS and incubated with the virus at the indicated MOI diluted in PBS at 4 °C for 60 min. The inoculum was aspirated and cells were washed with PBS (4 °C) three times. Cells were lysed in lysis buffer at indicated time points after a temperature shift to 37 °C and subjected to immunoblotting using anti-M1 and anti-NP antibodies.
For analysis of virus infection, serum-starved cells treated with inhibitors or left untreated were infected with PR8 at an MOI of 1 for 4 h at 37 °C, after which replicated virus particles in the nucleus were visualized by immunostaining with antibodies to NP; the fluorescence intensity of NP in the nucleus was measured.
Assessment of endocytosis
For detection of clathrin-independent and -dependent endocytosis, cells plated on collagen-coated glass-bottom dishes (35-mm-diameter; Asahi Techno Glass, Tokyo, Japan) were incubated with AlexaFluor-conjugated dextran (500 μg ml−1) and transferrin (500 μg ml−1) for 10 min at 37 °C, respectively, followed by extensive washing with PBS (dextran) or by PBS/HCl (pH 3.0, transferrin) to remove the non-internalized substances. Visualized vesicles were extracted with the use of the ‘granularity’ function of MetaMorph software and their fluorescence intensity was quantified.
siRNAs targeting murine ROCK1 or ROCK2 mRNAs (siROCK1#1: Mm_Rock1_1, siROCK1#2: Mm_Rock1_4, siROCK2#1: Mm_Rock2_2, siROCK2#2: Mm_Rock2_3) were obtained from Qiagen (Valencia, CA) and were introduced into cells by transient transfection with the use of the HiPerFect reagent (Qiagen). AllStars Negative Control siRNA (Qiagen) was used as a control.
RNA isolation and quantitative reverse transcriptase–PCR analysis
The total RNA was isolated from cells using an RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. First-strand cDNA was synthesized from 1.0 μg of total RNA by SuperScript III reverse transcriptase (Invitrogen). Quantitative PCR analysis was performed with the use of a StepOne real-time PCR system (Applied Biosystems, Foster City, CA) and the following primers: ROCK1-F, 5′-GGTATCGTCACAAGTAGCAGCATCA-3′; ROCK1-R, 5′-TAAACCAGGGCATCCAATCCA-3′; ROCK2-F, 5′-TTGCCAACAGTCCCTGGGTAG-3′; ROCK2-R, 5′-CGCCTGGCATGTACTCCATC-3′; GAPDH-F, 5′-AAGGGCTCATGACCACAGTC-3′; and GAPDH-R, 5′-GGATGCAGGGATGATGTTCT-3′. Data were normalized by the corresponding abundance of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA and then expressed relative to this value for control cells.
For data presented as box-and-whisker plots, the highest and lowest boundaries of the box represent the 25th and 75th percentiles, respectively, and the whiskers above and below the box designate the 5th and 95th percentiles, respectively; the line within the box indicates the median value. Such data were obtained from three independent experiments. Other data are presented as means±s.d. from three independent experiments, each performed in triplicate. Statistical analysis was performed by one-way analysis of variance followed by Student’s t-test.
How to cite this article: Fujioka, Y. et al. A Ca2+-dependent signalling circuit regulates influenza A virus internalization and infection. Nat. Commun. 4:2763 doi: 10.1038/ncomms3763 (2013).
Neumann, G., Noda, T. & Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931–939 (2009).
Matlin, K. S., Reggio, H., Helenius, A. & Simons, K. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91, 601–613 (1981).
Doxsey, S. J., Brodsky, F. M., Blank, G. S. & Helenius, A. Inhibition of endocytosis by anti-clathrin antibodies. Cell 50, 453–463 (1987).
Rust, M. J., Lakadamyali, M., Zhang, F. & Zhuang, X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat. Struct. Mol. Biol. 11, 567–573 (2004).
Chen, C. & Zhuang, X. Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc. Natl Acad. Sci. USA 105, 11790–11795 (2008).
Sieczkarski, S. B. & Whittaker, G. R. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol. 76, 10455–10464 (2002).
Fujioka, Y. et al. The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS One 6, e16324 (2011).
Vigil, D., Cherfils, J., Rossman, K. L. & Der, C. J. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat. Rev. Cancer 10, 842–857 (2010).
Nagai, T., Yamada, S., Tominaga, T., Ichikawa, M. & Miyawaki, A. Expanded dynamic range of fluorescent indicators for Ca2+ by circularly permuted yellow fluorescent proteins. Proc. Natl Acad. Sci. USA 101, 10554–10559 (2004).
Foreman, M. A., Smith, J. & Publicover, S. J. Characterisation of serum-induced intracellular Ca2+ oscillations in primary bone marrow stromal cells. J. Cell. Physiol. 206, 664–671 (2006).
Naik, S. et al. Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J. Biol. Chem. 280, 8722–8732 (2005).
Mochizuki, N. et al. Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065–1068 (2001).
Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345–9350 (1999).
Chen, B. J., Leser, G. P., Morita, E. & Lamb, R. A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 81, 7111–7123 (2007).
Upham, J. P., Pickett, D., Irimura, T., Anders, E. M. & Reading, P. C. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 84, 3730–3737 (2010).
Stray, S. J., Cummings, R. D. & Air, G. M. Influenza virus infection of desialylated cells. Glycobiology 10, 649–658 (2000).
Ebinu, J. O. et al. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 280, 1082–1086 (1998).
Kawasaki, H. et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc. Natl Acad. Sci. USA 95, 13278–13283 (1998).
Yamashita, S. et al. CalDAG-GEFIII activation of Ras, R-ras, and Rap1. J. Biol. Chem. 275, 25488–25493 (2000).
Bivona, T. G. et al. Phospholipase C gamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424, 694–698 (2003).
Wertz, I. E. & Dixit, V. M. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J. Biol. Chem. 275, 11470–11477 (2000).
Ehrhardt, C. et al. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol. 8, 1336–1348 (2006).
de Vries, E. et al. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7, e1001329 (2011).
Rossman, J. S., Leser, G. P. & Lamb, R. A. Filamentous influenza virus enters cells via macropinocytosis. J. Virol. 86, 10950–10960 (2012).
Eierhoff, T., Ludwig, S. & Ehrhardt, C. The influenza A virus matrix protein as a marker to monitor initial virus internalisation. Biol. Chem. 390, 509–515 (2009).
Ohba, Y., Kurokawa, K. & Matsuda, M. Mechanism of the spatio-temporal regulation of Ras and Rap1. EMBO J. 22, 859–869 (2003).
Lakadamyali, M., Rust, M. J., Babcock, H. P. & Zhuang, X. Visualizing infection of individual influenza viruses. Proc. Nat. Acad. Sci. USA 100, 9280–9285 (2003).
Mayor, S. & Pagano, R. E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 603–612 (2007).
Nanbo, A. et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6, e1001121 (2010).
Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629–635 (2002).
Norman, K. R. et al. The Rho/Rac-family guanine nucleotide exchange factor VAV-1 regulates rhythmic behaviors in C. elegans. Cell 123, 119–132 (2005).
Yoshizaki, H. et al. Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J. Cell Biol. 162, 223–232 (2003).
Itoh, R. E. et al. Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell Biol. 22, 6582–6591 (2002).
Grassart, A., Dujeancourt, A., Lazarow, P. B., Dautry-Varsat, A. & Sauvonnet, N. Clathrin-independent endocytosis used by the IL-2 receptor is regulated by Rac1, Pak1 and Pak2. EMBO Rep. 9, 356–362 (2008).
Akhtar, N. & Hotchin, N. A. RAC1 regulates adherens junctions through endocytosis of E-cadherin. Mol. Biol. Cell 12, 847–862 (2001).
Galiano, F. J., Ulug, E. T. & Davis, J. N. Overexpression of murine phosphatidylinositol 4-phosphate 5-kinase type Ibeta disrupts a phosphatidylinositol 4,5 bisphosphate regulated endosomal pathway. J. Cell Biochem. 85, 131–145 (2002).
Padron, D., Wang, Y. J., Yamamoto, M., Yin, H. & Roth, M. G. Phosphatidylinositol phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. J. Cell Biol. 162, 693–701 (2003).
Weernink, P. A. et al. Activation of type I phosphatidylinositol 4-phosphate 5-kinase isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42. J. Biol. Chem. 279, 7840–7849 (2004).
Sasaki, J. et al. Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type Iα. J. Exp. Med. 201, 859–870 (2005).
Park, S. J., Itoh, T. & Takenawa, T. Phosphatidylinositol 4-phosphate 5-kinase type I is regulated through phosphorylation response by extracellular stimuli. J. Biol. Chem. 276, 4781–4787 (2001).
Chatah, N. E. & Abrams, C. S. G-protein-coupled receptor activation induces the membrane translocation and activation of phosphatidylinositol-4-phosphate 5-kinase I alpha by a Rac- and Rho-dependent pathway. J. Biol. Chem. 276, 34059–34065 (2001).
Yang, S. A., Carpenter, C. L. & Abrams, C. S. Rho and Rho-kinase mediate thrombin-induced phosphatidylinositol 4-phosphate 5-kinase trafficking in platelets. J. Biol. Chem. 279, 42331–42336 (2004).
Yamazaki, M. et al. Phosphatidylinositol 4-phosphate 5-kinase is essential for ROCK-mediated neurite remodeling. J. Biol. Chem. 277, 17226–17230 (2002).
Ren, X. D. et al. Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells. Mol. Biol. Cell 7, 435–442 (1996).
Amano, M. et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275, 1308–1311 (1997).
Horowitz, L. F. et al. Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. J. Gen. Physiol. 126, 243–262 (2005).
MacMillan, D., Kennedy, C. & McCarron, J. G. ATP inhibits Ins(1,4,5)P3-evoked Ca2+ release in smooth muscle via P2Y1 receptors. J. Cell Sci. 125, 5151–5158 (2012).
Konig, R. et al. Human host factors required for influenza virus replication. Nature 463, 813–817 (2010).
Krizanova, O., Ciampor, F. & Veber, P. Influence of chlorpromazine on the replication of influenza virus in chick embryo cells. Acta Virol. 26, 209–216 (1982).
Ueda, M. et al. Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells. J. Virol. 84, 3068–3078 (2010).
Zhu, M. X. et al. Calcium signaling via two-pore channels: local or global, that is the question. Am. J. Physiol. Cell Physiol. 298, C430–C441 (2010).
Clapham, D. E. Calcium signaling. Cell 131, 1047–1058 (2007).
Matsu-ura, T. et al. Cytosolic inositol 1,4,5-trisphosphate dynamics during intracellular calcium oscillations in living cells. J. Cell Biol. 173, 755–765 (2006).
Ordonez-Moran, P. et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J. Cell Biol. 183, 697–710 (2008).
Wamhoff, B. R. et al. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ. Res. 95, 406–414 (2004).
Ying, Z., Giachini, F. R., Tostes, R. C. & Webb, R. C. PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA. Arterioscler. Thromb. Vasc. Biol. 29, 1657–1663 (2009).
Cook, D. R., Rossman, K. L. & Der, C. J. Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene (2013).
Ohba, Y. et al. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J. Biol. Chem. 275, 20020–20026 (2000).
Mercer, J. et al. Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc. Natl Acad. Sci. USA 107, 9346–9351 (2010).
Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803–833 (2010).
De Conto, F. et al. Differential infectious entry of human influenza A/NWS/33 virus (H1N1) in mammalian kidney cells. Virus. Res. 155, 221–230 (2011).
Tsuda, M., Tanaka, S., Sawa, H., Hanafusa, H. & Nagashima, K. Signaling adaptor protein v-Crk activates Rho and regulates cell motility in 3Y1 rat fibroblast cell line. Cell Growth Differ. 13, 131–139 (2002).
Kurokawa, K. & Matsuda, M. Localized RhoA activation as a requirement for the induction of membrane ruffling. Mol. Biol. Cell 16, 4294–4303 (2005).
Verges, M., Sebastian, I. & Mostov, K. E. Phosphoinositide 3-kinase regulates the role of retromer in transcytosis of the polymeric immunoglobulin receptor. Exp. Cell Res. 313, 707–718 (2007).
Lagana, A. et al. Regulation of the formation of tumor cell pseudopodia by the Na+/H+ exchanger NHE1. J. Cell Sci. 113, (Pt 20): 3649–3662 (2000).
Pleschka, S. et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301–305 (2001).
Yoshida, R. et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog. 5, e1000350 (2009).
Franke, B., Akkerman, J. W. & Bos, J. L. Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J. 16, 252–259 (1997).
Sander, E. E., ten Klooster, J. P., van Delft, S., van der Kammen, R. A. & Collard, J. G. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 147, 1009–1022 (1999).
Inuzuka, T., Tsuda, M., Kawaguchi, H. & Ohba, Y. Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem. Biophys. Res. Commun. 379, 510–513 (2009).
We thank S. Hattori, Y. Kawaoka, M. Matsuda, J. Miyazaki, A. Miyawaki, T. Tsuboi, A. Dautry-Varsat and T. Iwahara for expression plasmids, A. Takada for antibodies to NP, S. Darmanin for critical reading of the manuscript, M. Fujioka, N. Toyoda, M. Saito and A. Kikuchi for technical assistance, and members of the Ohba laboratory for helpful discussion. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#23114501) and from the Japan Society for the Promotion of Science (JSPS; #23390090 and #23659196) as well as by a grant from the Japan Science and Technology Agency. Y.F. is a JSPS research fellow.
The authors declare no competing financial interests.
About this article
Cite this article
Fujioka, Y., Tsuda, M., Nanbo, A. et al. A Ca2+-dependent signalling circuit regulates influenza A virus internalization and infection. Nat Commun 4, 2763 (2013). https://doi.org/10.1038/ncomms3763
Journal of Medical Virology (2020)
Environmental complex exposure and the risk of influenza-like illness among housewives: A case study in Shanxi Province, China
Ecotoxicology and Environmental Safety (2020)
Japanese Journal of Applied Physics (2020)
Equine Alphaherpesviruses Require Activation of the Small GTPases Rac1 and Cdc42 for Intracellular Transport
Scientific Reports (2019)